Supplementary Figure S10 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer | Synapse
September 16, 2024
Supplementary Figure S10 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Genomic features of patients with long-term response (LTR) compared to non-LTR and progressive disease (PD).
Preguntar a la IA
Me gusta
Guardar
Compartir
Cite This Study
Thummalapalli et al. (Mon,) studied this question.